Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy.

This study supports and corroborates the role of intravenous iron in preventing significant anaemia progression as well as providing a clinical benefit without the use of the much more expensive erythropoiesis-stimulating agents.

Extremely well done and worth reading.

– Michael Auerbach

Discuss this article on the Nataonline forum